Atrial fibrillation and cardiotoxicity: is transcatheter ablation an effective strategy?
Anno:
2024
Atrial fibrillation (AF) is the most commonly cardiac arrhythmia in clinical practice with an incidence of about 1.5-2% in the general population, rising to 20% in cancer patients. The use of antiarrhythmics in patients undergoing chemotherapy, besides being less effective in maintaining sinus rhythm, leads to an increase in…